Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,100 | 365,700 | 147,500 | 109,300 | 88,500 |
| Receivables | 470,200 | 453,000 | 451,700 | 422,800 | 380,000 |
| Inventories | 1,764,300 | 1,763,000 | 1,733,700 | 1,688,300 | 1,683,100 |
| Other current assets | 258,900 | 320,900 | 295,000 | 264,300 | 251,000 |
| TOTAL | $2,558,500 | $2,902,600 | $2,627,900 | $2,484,700 | $2,402,600 |
| Non-Current Assets | |||||
| PPE Net | 781,400 | 787,900 | 769,700 | 758,100 | 754,400 |
| Investments And Advances | 53,000 | 51,500 | 48,600 | 45,800 | 45,800 |
| Intangibles | 4,807,400 | 4,879,100 | 4,874,800 | 4,823,900 | 4,344,200 |
| Other Non-Current Assets | 60,900 | 55,000 | 83,700 | 87,900 | 92,300 |
| TOTAL | $5,702,700 | $5,773,500 | $5,776,800 | $5,715,700 | $5,236,700 |
| Total Assets | $8,261,200 | $8,676,100 | $8,404,700 | $8,200,400 | $7,639,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 199,700 | 264,000 | 173,800 | 137,200 | 162,600 |
| Other current liabilities | 386,500 | 506,600 | 445,500 | 482,000 | 471,700 |
| TOTAL | $778,200 | $1,250,700 | $908,500 | $919,000 | $966,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,022,800 | 2,024,900 | 2,225,200 | 2,213,400 | 1,612,200 |
| Other Non-Current Liabilities | 341,300 | 338,300 | 332,900 | 330,300 | 337,300 |
| TOTAL | $2,804,800 | $2,816,200 | $3,020,800 | $2,953,100 | $2,358,000 |
| Total Liabilities | $3,583,000 | $4,066,900 | $3,929,300 | $3,872,100 | $3,324,700 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 160,889 | 160,327 | 159,113 | 158,368 | 157,597 |
| Common Shares | 734,000 | 734,000 | 734,000 | 734,000 | 734,000 |
| Retained earnings | 6,217,800 | 6,136,800 | 6,046,200 | 6,002,900 | 5,935,600 |
| Other shareholders' equity | -239,100 | -186,300 | -196,700 | -281,100 | -184,400 |
| TOTAL | $4,678,200 | $4,609,200 | $4,475,400 | $4,328,300 | $4,314,600 |
| Total Liabilities And Equity | $8,261,200 | $8,676,100 | $8,404,700 | $8,200,400 | $7,639,300 |